Skip to main content
Topics
Video
Provider
Payer
Pharma
ANZ
ASIA
EMEA
Global Edition
clinical development platform
PhaseV scores $50M for AI clinical trial platform
By
Jessica Hagen
|
03:10 pm |
May 13, 2025
The company uses AI and ML to assist biopharma companies with clinical trials and will use the funds to expand its precision medicine and clinical development tools.
